Posted by AGORACOM-JC
at 5:54 PM on Wednesday, October 28th, 2020
Avicanna (AVCN :TSX) (AVCN : OTCQX) ( 0NN: FSE) is a vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global marketplace.
When we say vertically integrated, we mean it. Avicanna has 4 fully operating divisions to address the entire market for Cannabis products as follows:
1. The company has a full line of high end CBD based skin care products serving the consumer retail segment with Canadian distribution through Medical Cannabis by Shoppers, as well as global distribution later this year.
2. Avicanna’s superior medical cannabis line also features products distributed through Medical Cannabis by Shoppers, the online arm of Canada’s largest drugstore chain. In addition, the company recently received certification and authorization for the sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia.
3. Avicanna also hosts a full pipeline of Pharmaceuticals in various stages of trials to address Dermatology, Psychiatry, Neurology, Pain and Oncology. Three of the company’s products are already as far as phase 2.
Posted by AGORACOM-JC
at 5:30 PM on Wednesday, October 28th, 2020
Six new clinics installing SIAscopy™ on Dermsecure™ telemedicine platform in the next three weeks across Ontario and Saskatchewan
MedX enters into a sales agency agreement with specialty medical device distribution group Ziemer Professional Corp., targeting sales efforts within the medical, athletic, and pain management clinic markets
MedX Health Corp. (“MedX” or the “Company”) (TSX-V:MDX), the global leader in teledermatology, announces that it has completed a sales agency agreement with the Ziemer Professional Corporation. Mr. Paul Ziemer, President, has 20 years of experience in medical device sales and medical clinic operations. “I have been working with the MedX team to develop a go-to market strategy and I am pleased to announce that the first six clinics will roll-out in the next three weeks with installations across Ontario and Saskatchewan. Preparations are already in place for additional installations in Canada and the USA for December and early 2021,” stated Mr. Ziemer.
“COVID-19 has almost doubled the wait times in order to see a Dermatologist. MedX’s DermSecure™ teledermatology platform provides a perfect solution to this problem. I have received tremendous interest from my client base and expect rapid growth in both the USA and Canada,” Mr. Ziemer added.
“Mr. Ziemer’s enthusiasm and detailed knowledge of the economic drivers in the clinic market have been invaluable as we begin our roll-out strategy. Mr. Ziemer has a wide network and strong relationships with numerous medical clinics and practitioners. We believe he will develop a solid customer base in a number of key markets for MedX, and we look forward to supporting Mr. Ziemer and his team in their sales and marketing efforts,” commented Mr. Mike Druhan, President, Dermatological Products and Services.
About Ziemer Professional Corp.
Ziemer Professional Corporation has been partnering with health care innovators for over 20 years. We have a strong focus on delivering new and innovative medical technologies to medical/athletic clinics throughout North America and internationally. Areas of experience include Diabetic Wound Care, Peripheral Neuropathy, Biomechanical Gait and Posture Analysis, Telemedicine/Remote Patient Monitoring. ZPC provides sales support as well as educational leadership to its partners, patients and clinical customers. Improving patient access to preventative technologies is top of mind with a specific focus on delivering patient care to remote communities including a special relationship with First Nations.
About MedX
MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy™ on DermSecure™ telemedicine platform, utilizing its SIAscopy™ technology. SIAscopy™ is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA, TGA and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union, Brazil and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com
Forward Looking Statements
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of applicable Canadian securities legislation. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the Company’s limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the Company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the Company’s projections or forward-looking statements. All forward looking statements in this press release are based on information available to the Company as of the date hereof, and the Company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 1:55 PM on Wednesday, October 28th, 2020
TORONTO , Oct. 28, 2020- David E. Luxton , Executive Chairman, KWESST Micro Systems Inc. (TSXV: KWE), shares his company’s story in an interview with TMX Group.
The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current business environment. To see the latest C-Suite at The Open videos visit https://www.tmxmoney.com/en/csuite.html .
About KWESST Micro Systems Inc. (TSXV: KWE)
KWESST Micro Systems Inc. is a proud leader in advancing the modern networked capability of soldiers and responders, including the networked Soldier Systems mission of NATO and its allies, with niche applications that make a critical difference to safety and effectiveness. For more information visit: https://www.kwesst.com/
About TMX Group (TSX: X)
TMX Group’s key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities and fixed income. Toronto Stock Exchange , TSX Venture Exchange , TSX Alpha Exchange , The Canadian Depository for Securities , Montréal Exchange , Canadian Derivatives Clearing Corporation , Trayport and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, technology solutions, data products and other services to the global financial community. TMX Group is headquartered in Toronto and operates offices across North America (Montréal, Calgary , Vancouver and New York ), as well as in key international markets including London , Beijing and Singapore . For more information about TMX Group, visit our website at www.tmx.com . Follow TMX Group on Twitter: @TMXGroup .
Posted by AGORACOM-JC
at 1:47 PM on Wednesday, October 28th, 2020
SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. ImagineAR and NFL Alumni Academy recently signed a 5 year partnership agreement. In addition, the company signed a two-year agreement with Valencia C.F. of La Liga to provide interactive Augmented Reality experiences for almost 7 million fans around the world. Learn More.
AR isn’t just ‘exciting’, it’s practical
Augmented reality might seem like a daunting new frontier for the average business, but adopting this new technology is a lot easier than it seems
With an anticipated 3.8 billion smartphone users in 2021, more people are using mobile tech to experience the world, from enhanced museum tours to Animoji
If you haven’t already considered it, AR can be a smart, practical form of smart marketing and branding.
Augmented reality might seem like a daunting new frontier for the average business, but adopting this new technology is a lot easier than it seems. With an anticipated 3.8 billion smartphone users in 2021, more people are using mobile tech to experience the world, from enhanced museum tours to Animoji. If you haven’t already considered it, AR can be a smart, practical form of smart marketing and branding.
First, it’s important to distinguish between augmented reality and virtual reality. Virtual reality is an almost wholly-digital experience that requires special hardware to immerse yourself in a new environment. Augmented reality is a combination of the digital and physical worlds, where the former is often “layered” over the latter. If you’ve used custom Snapchat filters or played Pokemon Go, you’ve already tried AR without even realizing it.
But the great thing about AR is that it doesn’t require buying new hardware. Virtual reality, while still an exciting new realm, isn’t as widely accessible as AR. For starters, you need pricey new gadgets to play around in VR, but anyone with a smartphone and an internet connection can tap into a well-crafted AR experience.
“The biggest benefit of AR is the simplicity with which you can build on top of the existing world that a user is already familiar with to teach them new things or show them new information that was previously unavailable,” says Gal Oppenheimer, who manages Contentstack’s Solutions Architecture Team. AR has, for instance, become a huge part of our daily reality, with Zoom virtual backgrounds helping people continue to meet and work collaboratively regardless of their environment.
Speaking to Oppenheimer and Contentstack’s marketing director Varia Makagonova reveals that augmented reality is a particularly effective, forward-thinking strategy for companies in retail, museums/education, and home improvement; AR works best to convey important, relevant information to customers in a quick, intuitive way. Best of all, it’s surprisingly straightforward to implement, especially if you’re working with an experienced content management team.
Great AR needs great content
As a headless CMS, Contentstack leads the way in helping businesses create innovative content experiences. In 2020, blogs and websites are no longer the main avenues of brand communication – modern customer experiences can include everything from chatbots and apps to new types of streaming media. Contentstack helps you adapt to new technology quickly and seamlessly, no matter the platform.
“When people look at AR, they only see the end experience,” says Oppenheimer. “And what people don’t realize is really there are two pieces to an AR experience. There’s the experience the consumer sees… and that is really just a 3D model, a color map, and a rendering library.” Then there’s the content, which can require just as much attention, depending on the scope of a company’s product lineup. This is where Contentstack comes into play.
A great content platform needs to be streamlined and easy to use, especially if you’re going to be working with new channels and touchpoints like Augmented Reality applications. With the right tools, it’s easy to build a well-organized, flexible content library that can be used to power all kinds of content-rich experiences.
And when it comes to retail, that often means making sure you can easily plug in personalization and e-commerce technologies into these experiences. As Oppenheimer points out, “it doesn’t matter if you have the biggest library of content available for your AR application to use. If the customer doesn’t see the one product that they are looking for to try on or learn more about, the app has not done its job for them.”
Building and tending to a useful content experience doesn’t have to be painful, though. “We have customers that have well over 2 million products in their Contentstack,” Oppenheimer says. “And when they do a release, sometimes that’s 200 products going live the same day… being able to facilitate that process easily, and then making sure that content appears in the mobile application that has all the rich AR content at the end, that’s where we come in.”
With the preview site now open to the public, beginning in early November, Liquid Avatar users will be able to add custom-designed and limited availability icons from leading pop culture, comic book, fantasy, manga, and contemporary Artists.
Through the Liquid Avatar Marketplace, users will be able to buy custom and limited availability icons from key Artists, adding to their self-created icons
Liquid Avatar users will be able to buy, store, use and, in early 2021, sell and trade custom purchased icons through their personal lockers for as little as $2.99 USD per custom icon
TORONTO, ON / October 28, 2020 /KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN” or “KABN North America“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the US, is pleased to announce that its Liquid Avatar platform (www.liquidavatar.com), is ready to offer users a new type of Avatar experience through the Liquid Avatar Marketplace (“Marketplace”) (www.liquidavatarmarketplace.com). With the preview site now open to the public, beginning in early November, Liquid Avatar users will be able to add custom-designed and limited availability icons from leading pop culture, comic book, fantasy, manga, and contemporary Artists. The icons will also come complete with an innovative digital authentication solution that will allow users to manage their ownership and transfer of Liquid Avatar icons, adding a collectability component to the platform.
The Liquid Avatar App, available for web, iOS and Android, empowers users to create high quality personalized digital icons from the App’s Free Creation Studio. Each icon can represent a different facet of a user’s online personality, or personas, like work, school, family, friends, gaming, social and other segments. These icons, in conjunction with KABN ID and KABN’s Self Sovereign Identity wallet and digital credentials, gives users the ability to verify, manage and control their Digital Identity and use Liquid Avatars to share permission-based data. Sharing your Liquid Avatar is as easy as sending an image through email, text or social media. Liquid Avatar puts the ownership of online identity where it belongs – in the hands of the owner — allowing users to share what information they want, when they want and with whom they want.
Through the Liquid Avatar Marketplace, users will be able to buy custom and limited availability icons from key Artists, adding to their self-created icons. Liquid Avatar users will be able to buy, store, use and, in early 2021, sell and trade custom purchased icons through their personal lockers for as little as $2.99 USD per custom icon.
With over two dozen leading artists and over 350 icons already in design, all Liquid Avatars purchased from the Marketplace will be supported with a unique Digital Certificate of Authenticity (DCA), allowing each custom icon to have its own Blockchain identifier that can be transferred from one user to another. This methodology created by the KABN Network and supported by IBM’s Hyper Leger Blockchain technologies, will allow users to buy, sell and trade custom avatars and record the transfer and ownership of these collectible icons. Once reselling and trading of Liquid Avatar custom icons is available, the Marketplace will charge a fee that will allow for the issuance, recording, and management of the DCA’s and the transfer of ownership of digitized assets.
“Using DCAs to authenticate an asset is similar to how collectibles such as sports cards, comic books, movie props, and signed memorabilia are verified in the “real” world, but adds an innovative Blockchain solution to the mix,” said RJ Reiser, Chief Business Development Officer. “We believe that digitized assets will represent a viable way for online audiences to be part of the growing collector community and that Liquid Avatar custom icons are part of the key business strategies for KABN North America’s revenue programs.”
Liquid Avatar icons can also be created and used for businesses, events, associations, and other groups to share content and offers with their known and verified users.
Additional items like t-Shirts, hoodies, and many others, featuring certain Liquid Avatars will be available for sale starting early December, and there will be a host of promotions featuring unique offers to launch the site.
“KABN North America’s mandate is to start its revenue generating program this quarter and Liquid Avatar custom icons represent a potentially significant opportunity to create revenue, promotion and value for the Company,” said David Lucatch, CEO. “Online gaming and digital and physical collectibles are multi-billion-dollar industries and anyone who knows a Fortnite player or other gamer knows that players are always looking to acquire the latest in cosmetic enhancements. These players, along with sports, comic book, movie and fantasy collectors, are the primary audiences for our custom and collectible Liquid Avatars.”
KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from its use of their online identity. KABN propriety technology suite includes 4 key products:
Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allows users to manage and control their Digital Identity and to use Liquid Avatars to share public and permission based private data when they want and with whom they want. www.liquidavatar.com
KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.
KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives. www.kabncard.com
KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.
KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com
David Lucatch Chief Executive Officer 647-725-7742 Ext. 701 [email protected]
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
Forward-Looking Information and Statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of the Company to generate revenues, roll out new programs and to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.
By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.
Posted by AGORACOM-JC
at 8:36 AM on Wednesday, October 28th, 2020
Announced the completion of the second phase of three deliverables under a contract to support a U.S. military customer, featuring the Company’s signature Tactical Awareness and Situational Control System (TASCS) and its Integrated Fires Module (IFM).
Results of phase one and two, now being summarized into a phase three report, confirm that the TASCS IFM achieves greater accuracy and faster response times on indirect fire systems like mortars, improving soldier survivability and operational effectiveness
“We’re encouraged that the results and user feedback from these live-fire exercises have further increased customer confidence in the TASCS system,” said Jeff MacLeod, KWESST Founder and CEO, who added, “We’re pleased at the rapid pace as well as the outcome of these exercises, especially with such a key U.S. military customer, who has now requested a proposal from the Company for a next phase of expanded exercises to start in early 2021.”
Ottawa, Ontario–(October 28, 2020) – KWESST Micro Systems Inc. (TSXV: KWE) (“KWESST” or “the Company”) today announced the completion of the second phase of three deliverables under a contract to support a U.S. military customer, featuring the Company’s signature Tactical Awareness and Situational Control System (TASCS) and its Integrated Fires Module (IFM).
On September 22nd, 2020, the Company announced the completion of the first deliverable to provide real-time situational awareness and targeting information from a drone to ground forces and their mortar weapons systems. The second deliverable, just completed, incorporated customer feedback from the first phase to optimize TASCS operating procedures.
The results of phase one and two, now being summarized into a phase three report, confirm that the TASCS IFM achieves greater accuracy and faster response times on indirect fire systems like mortars, improving soldier survivability and operational effectiveness.
“We’re encouraged that the results and user feedback from these live-fire exercises have further increased customer confidence in the TASCS system,” said Jeff MacLeod, KWESST Founder and CEO, who added, “We’re pleased at the rapid pace as well as the outcome of these exercises, especially with such a key U.S. military customer, who has now requested a proposal from the Company for a next phase of expanded exercises to start in early 2021.”
As stated in the Company’s announcement of September 22nd 2020, contracted exercises like this with military customers are an important phase in the process towards potential introduction into service. The Company also noted at the time that at least two other NATO military customers have similar requirements, with demonstration contracts for the TASCS IFM system currently under consideration.
About KWESST
KWESST develops and commercializes high-value ultra-miniaturized technology applications that make a critical difference to the safety and operational effectiveness of personnel in the defence and security industries. The company’s current portfolio of unique proprietary offerings include: its signature TASCSTM (Tactical and Situational Control System) for real-time awareness and targeting information from any source (including drones) streamed directly to users’ smart devices and weapons; the autonomous GreyGhostTM soldier-portable micro drone missile system that defends against small hostile drones including swarms using high-speed kinetic impact; a Ground Laser Defence system to counter the emerging threat of weaponized lasers against personnel; and, the PhantomTM electronic battlefield decoy system to mask the electromagnetic signature of friendly forces with decoy signatures at false locations to deceive and confuse adversaries. All systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems including Frontline, Edge, Killswitch and ATAK (Android Tactical Assault Kit) among others. KWESST also has developmental “smart ordnance” projects including its “Shot Counter” system, which records the number and type of rounds fired, for optimized firearms maintenance and performance. The Company is headquartered in Ottawa, Canada, with representative offices in Washington, DC, London, UK and Abu Dhabi, UAE. KWESST trades on the TSX Venture Exchange under the symbol KWE.
This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the timing for the commencement of trading and the plans and operations of KWESST after giving effect to the Qualifying Transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. KWESST disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Posted by AGORACOM-JC
at 7:22 AM on Wednesday, October 28th, 2020
ELSE rapidly expands distribution to provide nationwide product availability in retail, Amazon.com and Else’s e-store
Company expects to begin its initial store distribution via KeHE Distributors in western and southern regions of the United States as early as late November 2020
To include up four regional accounts and one national key account, totaling 380 stores in advance of the Christmas season.
“We are very encouraged with the aggressive interest we have received for our product. Parents and families have waited a long time for a plant-based alternative to dairy-based baby nutrition….” said Mrs. Hamutal Yitzhak , CEO and Co-Founder of Else.
VANCOUVER, BC , Oct. 28, 2020 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (” Else ” or the ” Company “), a commercial stage developer of plant-based alternatives to dairy-based baby nutrition, is pleased to provide an update on upcoming availability of the Company’s products in U.S. retail stores.
The Company expects to begin its initial store distribution via KeHE Distributors in western and southern regions of the United States as early as late November 2020 , and is to include up four regional accounts and one national key account, totaling 380 stores in advance of the Christmas season.
U.S. Retail Distribution and Rollout
Following the recent successful e-store and Amazon launch for its plant-based toddler nutrition line, Else has been working diligently through its network of retail brokers and KeHE Distributors on strategic ‘Brick & Mortar’ account listings across various critical US regions.
“We are very encouraged with the aggressive interest we have received for our product. Parents and families have waited a long time for a plant-based alternative to dairy-based baby nutrition. Soon parents across the United States will be able to find our product at stores near them in addition to being able to order online,” said Mrs. Hamutal Yitzhak , CEO and Co-Founder of Else.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Posted by AGORACOM-JC
at 5:38 PM on Tuesday, October 27th, 2020
WHY KWESST? HERE’S SOME GREAT REASONS
1. KWESST is a leader in defensive technologies that increase the capabilities of soldiers,
including those of NATO and its allies.
2. These technologies make a critical difference to soldier safety and effectiveness.
3. The Leadership team experience spans decades and hundreds of millions of dollars in military and homeland security contracts.
4. KWESST develops next-generation systems for forces around the world, with a particular focus on special forces among NATO countries and their allies.
5. KWESST partners with globally recognized equipment manufacturers to integrate its
systems into their solutions to create high value-add products for global customers.
Announced the elevation of its affiliation with SAMSUNG Electronics America Inc. to “USA Partner” status
KWESST will be employing the SAMSUNG S20TE tactical smart phone in the production version of the Company’s Tactical Awareness and Situational Control System (TASCS) and for its Integrated Fires Module (IFM) for networked targeting on soldiers’ weapons
SAMSUNG S20TE device, also known as the Galaxy S20 Tactical Edition, is the latest mission-ready military smartphone built and proven by operators in special operations for rapid information capture, sharing and analysis in diverse operating environments
6. KWESST provides small cap investors with a rare opportunity to invest in a high-growth,
technology driven, global defence company with:
Tier-1 Customers
Global Customers
Proprietary Technologies
Diversified Products
Globally Renowned Executive Team With Massive Successful Track Records
FULL DISCLOSURE: Kwesst Micro Systems Inc. is an advertising client of AGORA Internet Relations Corp.
Posted by AGORACOM-JC
at 5:12 PM on Tuesday, October 27th, 2020
R&G Relief & Go™ CBD Spray product has successfully passed the detailed safety assessment requirements under Regulation No 1223/2009 of The European Parliament and of the Council on Cosmetic Products and has received a Cosmetic Product Safety Report (“CPSR”) for product marketing in the European Union
“We are thrilled to receive another validation of our feasibility and to pass the EU regulation requirements for the marketing of our Relief & Go CPD Spray product”, says Iris Bincovich, Co-founder and CEO of Innocan, “This is a major accomplishment for our team and an exciting milestone of our future”.
Herzliya, Israel and Calgary, Alberta–(October 27, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan”), is pleased to announce that its R&G Relief & Go™ CBD Spray product has successfully passed the detailed safety assessment requirements under Regulation No 1223/2009 of The European Parliament and of the Council on Cosmetic Products and has received a Cosmetic Product Safety Report (“CPSR”) for product marketing in the European Union.
Innocan Israel, a wholly owned subsidiary of the Company, with its patent-pending unique formulation “Relief & Go CBD Spray” combines the known benefits of active ingredients such as Menthol and Camphor with CBD and Magnesium (more than 40% in the formula) to help the body relax and recover for sport-performing professionals.
Innocan Israel’s CTO, Mr. Nir Avram has over 30 years of experience as a senior consultant in the area of pharmaceuticals and cosmetics. Nir consults in diverse areas of expertise including pharmaceutical and cosmetic innovations, generic formulations, and synthesis of novel materials, in connection with start-ups and established companies.
Nir is Vice President of Research & Development at Emilia Cosmetics Israel and Emilia Resources in the US. Prior to this he was VP of R&D at Careline, a leading cosmetics and toiletries manufacturer, and a member of the pharmaceutical innovation team at Perrigo.
“We are thrilled to receive another validation of our feasibility and to pass the EU regulation requirements for the marketing of our Relief & Go CPD Spray product”, says Iris Bincovich, Co-founder and CEO of Innocan, “This is a major accomplishment for our team and an exciting milestone of our future”.
About Innocan
Innocan Israel is a pharmaceutical tech company that focuses on the development of several drug delivery platforms containing CBD. Innocan Israel and Ramot at Tel Aviv University, are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the Covid-19 Corona Virus using CBD. CBD-Loaded Exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.
Innocan Israel signed a worldwide exclusive license agreement with Yissum, the commercial arm of The Hebrew University of Jerusalem, to develop a CBD drug delivery platform based on a unique-controlled release liposome to be administrated by injection. Innocan Israel plans, together with Professor Berenholtz Head of the Laboratory of Membrane and Liposome Research of The Hebrew University of Jerusalem, to test the liposome platform on several potential indications. Innocan Israel is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for the relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan Israel each have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.
For further information, please contact:
Innocan Pharma Corporation Iris Bincovich, CEO +972-54-3012842 [email protected]
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Caution regarding forward-looking information
Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.
Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.
Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable
